Bacillus cereus from the environment is genetically related to the highly pathogenic B. cereus in Zambia

The Journal of Veterinary Medical Science
Hirohito OgawaHideaki Higashi

Abstract

To follow-up anthrax in Zambia since the outbreak in 2011, we have collected samples from the environment and the carcasses of anthrax-suspected animals, and have tried to isolate Bacillus anthracis. In the process of identification of B. anthracis, we collected two isolates, of which colonies were similar to B. anthracis; however, from the results of identification using the molecular-based methods, two isolates were genetically related to the highly pathogenic B. cereus, of which clinical manifestation is severe and fatal (e.g., pneumonia). In this study, we showed the existence of bacteria suspected to be highly pathogenic B. cereus in Zambia, indicating the possibility of an outbreak caused by highly pathogenic B. cereus.

References

Jun 1, 2000·Applied and Environmental Microbiology·E HelgasonA B Kolstø
Jul 23, 2003·Environmental Microbiology·G B JensenJ Mahillon
May 20, 2004·Journal of Bacteriology·Leyla SlamtiDidier Lereclus
Jun 21, 2011·Diagnostic Microbiology and Infectious Disease·Jiwei ZhangTakayuki Ezaki
Apr 5, 2012·Tropical Doctor·Mudenda B Hang'ombeHideaki Higashi
Mar 8, 2014·Genome Announcements·Naomi OhnishiHideaki Higashi

❮ Previous
Next ❯

Citations

Feb 6, 2020·Biological & Pharmaceutical Bulletin·Masataka OdaGo Kamoshida

❮ Previous
Next ❯

Datasets Mentioned

BETA
GTC03221

Methods Mentioned

BETA
PCR

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Related Papers

Gigiena truda i professional'nye zabolevaniia
N V ObnosovaM Z Vermul
PLoS Pathogens
Richard T OkinakaPaul Keim
Nihon saikingaku zasshi. Japanese journal of bacteriology
Eiko Yabuuchi
Ryōikibetsu shōkōgun shirīzu
K WatanabeN Takeda
© 2021 Meta ULC. All rights reserved